Compare GRPN & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRPN | DRTS |
|---|---|---|
| Founded | 2008 | 2015 |
| Country | United States | Israel |
| Employees | N/A | 121 |
| Industry | Advertising | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 582.2M | 641.6M |
| IPO Year | 2011 | N/A |
| Metric | GRPN | DRTS |
|---|---|---|
| Price | $17.34 | $10.39 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $33.67 | $8.67 |
| AVG Volume (30 Days) | ★ 2.5M | 653.9K |
| Earning Date | 05-07-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,843,877,000.00 | N/A |
| Revenue This Year | $5.55 | N/A |
| Revenue Next Year | $6.63 | $699.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.17 | $2.81 |
| 52 Week High | $41.26 | $10.80 |
| Indicator | GRPN | DRTS |
|---|---|---|
| Relative Strength Index (RSI) | 60.22 | 68.48 |
| Support Level | $17.21 | $6.59 |
| Resistance Level | $18.81 | N/A |
| Average True Range (ATR) | 1.38 | 0.81 |
| MACD | 0.13 | 0.25 |
| Stochastic Oscillator | 70.18 | 87.57 |
Groupon Inc is a globalised, scaled two-sided marketplace that connects consumers to merchants. Its categories include Local: local inventory includes things to do, beauty and wellness, food and drink, home and automotive services, online services, as well as other types of experiences and services. Goods: Includes merchandise across multiple product lines, such as electronics, sporting goods, jewelry, toys, household items and apparel, and Travel: Features travel experiences at both discounted and market rates, including hotels, airfare, and package deals covering both domestic and international travel. The company operates in two segments, North America and International, with the majority of revenue from the Local category from the North America Segment.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.